InvestorsHub Logo
Followers 272
Posts 53131
Boards Moderated 3
Alias Born 08/16/2008

Re: MiamiGent post# 165

Wednesday, 04/26/2023 6:50:11 PM

Wednesday, April 26, 2023 6:50:11 PM

Post# of 292
US FDA approves Seres Therapeutics' pill for deadly C. difficile infections
REUTERS

https://stockcharts.com/h-sc/ui?s=MCRB

April 26 (Reuters) - The U.S. health regulator on Wednesday approved Seres Therapeutics Inc's (MCRB) pill for treating a type of bacterial infection, giving an easier and standardized option to patients who often have to rely on individual donors for fecal transplants. (Reporting by Raghav Mahobe and Aditya Samal in Bengaluru; Editing by Shinjini Ganguli)
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MCRB News